Transfection of drug-specific T-cell receptors into hybridoma cells: Tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds

Molecular Pharmacology

Volumn 70, Issue 1, 2006, Pages 356-365

  Schmid, Daphné Anne ^a   Depta, Jan Paul Heribert ^a   Lüthi, Michael ^a   Pichler, Werner Joseph ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; INTERLEUKIN 2; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLONE; SULFADIMETHOXINE; SULFADOXINE; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFAMETHOXYPYRIDAZINE; SULFANILAMIDE; SULFAPYRIDINE; SULFASOMIDINE; T LYMPHOCYTE RECEPTOR;

ALPHA CHAIN; ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BETA CHAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG BINDING; DRUG CROSS REACTIVITY; DRUG MONITORING; DRUG SPECIFICITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYBRIDOMA CELL CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD3; ANTIGENS, CD4; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELLS, CULTURED; CIPROFLOXACIN; CROSS REACTIONS; DRUG INTERACTIONS; FLOW CYTOMETRY; HUMANS; HYBRIDOMAS; INTERLEUKIN-2; MICE; NORFLOXACIN; QUINOLONES; RECEPTORS, ANTIGEN, T-CELL; SULFAMETHIZOLE; SULFAMETHOXAZOLE; SULFANILAMIDES; T-LYMPHOCYTES; TIME FACTORS; TRANSFECTION;

EID: 33745261626     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.021576     Document Type: Article

References (40)

1. Bala S, Weaver J, and Hastings KL (2005) Clinical relevance of preclinical testing for allergic side effects. Toxicology 209:195-200.
2. Blank U, Boitel B, Mege D, Ermonval M, and Acuto O (1993) Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma. Eur J Immunol 23:3057-3065.
3. Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, and Pichler WJ (1995) Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 155:2670-2678.
4. Burkhart C, Britschgi M, Strasser I, Depta JP, von Greyerz S, Barnaba V, and Pichler WJ (2002) Non-covalent presentation of sulfamethoxazole to human CD4+ T cells is independent of distinct human leucocyte antigen-bound peptides. Clin Exp Allergy 32:1635-1643.
5. Depta JP, Altznauer F, Gamerdinger K, Burkhart C, Weltzien HU, and Pichler WJ (2004) Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. J Allergy Clin Immunol 113:519-527.
6. Effros RB and Pawelec G (1997) Replicative senescence of T cells: does the Hayflick Limit lead to immune exhaustion? Immunol Today 18:450-454.
7. Fleischer B, Necker A, Leget C, Malissen B, and Romagne F (1996) Reactivity of mouse T-cell hybridomas expressing human Vbeta gene segments with staphylococcal and streptococcal superantigens. Infect Immun 64:987-994.
8. Fleischer B and Schrezenmeier H (1988) T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J Exp Med 167:1697-1707.
9. Forsgren A, Schlossman SF, and Tedder TF (1987) 4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro. Antimicrob Agents Chemother 31:768-773.
10. Gamerdinger K, Moulon C, Karp DR, Van Bergen J, Koning F, Wild D, Pflugfelder U, and Weltzien HU (2003) A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med 197:1345-1353.
11. Grabstein K, Eisenman J, Mochizuki D, Shanebeck K, Conlon P, Hopp T, March C, and Gillis S (1986) Purification to homogeneity of B cell stimulating factor. A molecule that stimulates proliferation of multiple lymphokine-dependent cell lines. J Exp Med 163:1405-1414.
12. Lefranc MP (2001) The T Cell Receptor Facts Book, Academic Press, San Diego.
13. Leo O, Foo M, Sachs DH, Samelson LE, and Bluestone JA (1987) Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci USA 84:1374-1378.
14. Letourneur F and Malissen B (1989) Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin. Eur J Immunol 19:2269-2274.
15. Manfredi M, Severino M, Testi S, Macchia D, Ermini G, Pichler WJ, and Campi P (2004) Detection of specific IgE to quinolones. J Allergy Clin Immunol 113:155-160.
16. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, and Pichler WJ (1995) Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine. J Immunol 155:462-472.
17. Migliaccio M, Raj K, Menzel O, and Rufer N (2005) Mechanisms that limit the in vitro proliferative potential of human CD8+ T lymphocytes. J Immunol 174:3335-3343.
18. Naisbitt DJ, Britschgi M, Wong G, Farrell J, Depta JP, Chadwick DW, Pichler WJ, Pirmohamed M, and Park BK (2003a) Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype and cytokine profile of drug-specific T cell clones. Mol Pharmacol 63:732-741.
19. Naisbitt DJ, Farrell J, Wong G, Depta JP, Dodd CC, Hopkins JE, Gibney CA, Chadwick DW, Pichler WJ, Pirmohamed M, et al. (2003b) Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 111:1393-1403.
20. Naisbitt DJ, Gordon SF, Pirmohamed M, and Park BK (2000) Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 23:483-507.
21. Naisbitt DJ, Pirmohamed M, and Park BK (2003c) Immunopharmacology of hypersensitivity reactions to drugs. Curr Allergy Asthma Rep 3:22-29.
22. Pichler WJ (2001) Predictive drug allergy testing: an alternative viewpoint. Toxicology 158:31-41.
23. Pichler WJ (2002) Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2:301-305.
24. Pichler WJ (2003) Delayed drug hypersensitivity reactions. Ann Intern Med 139:683-693.
25. Pichler WJ (2005) Direct T-cell stimulations by drugs-bypassing the innate immune system. Toxicology 209:95-100.
26. Roujeau JC and Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331:1272-1285.
27. Schmid DA, Depta JPH, and Pichler WJ (2006) T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 36:59-69.
28. Schnyder B, Burkhart C, Schnyder-Frutig K, von Greyerz S, Naisbitt DJ, Pirmohamed M, Park BK, and Pichler WJ (2000) Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 164:6647-6654.
29. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, and Pichler WJ (1997) Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Investig 100:136-141.
30. Shimonkevitz R, Kappler J, Marrack P, and Grey H (1983) Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing. J Exp Med 158:303-316.
31. Sieben S, Kawakubo Y, Al Masaoudi T, Merk HF, and Blomeke B (2002) Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol 109:1005-1011.
32. Vollmer J, Weltzien HU, Dormoy A, Pistoor F, and Moulon C (1999) Functional expression and analysis of a human HLA-DQ restricted, nickel-reactive T cell receptor in mouse hybridoma cells. J Investig Dermatol 113:175-181.
33. Vollmer J, Weltzien HU, Gamerdinger K, Lang S, Choleva Y, and Moulon C (2000) Antigen contacts by Ni-reactive TCR: typical alphass chain cooperation versus alpha chain-dominated specificity. Int Immunol 12:1723-1731.
34. von Greyerz S, Bultemann G, Schnyder K, Burkhart C, Lotti B, Hari Y, and Pichler WJ (2001) Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. Int Immunol 13:877-885.
35. von Greyerz S, Zanni MP, Frutig K, Schnyder B, Burkhart C, and Pichler WJ (1999) Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human ab+ T cell clones. J Immunol 162:595-602.
36. Wyss-Coray T, Gallati H, Pracht I, Limat A, Mauri D, Frutig K, and Pichler WJ (1993) Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones. Eur J Immunol 23:3350-3357.
37. Yawalkar N, Hari Y, Frutig K, Egli F, Wendland T, Braathen LR, and Pichler WJ (2000) T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Investig Dermatol 115:647-652.
38. Zanni MP, Mauri-Hellweg D, Brander C, Wendland T, Schnyder B, Frei E, von Greyerz S, Bircher A, and Pichler WJ (1997) Characterization of lidocaine-specific T cells. J Immunol 158:1139-1148.
39. Zanni MP, von Greyerz S, Schnyder B, Brander KA, Frutig K, Hari Y, Valitutti S, and Pichler WJ (1998a) HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. J Clin Investig 102:1591-1598.
40. Zanni MP, von Greyerz S, Schnyder B, Wendland T, and Pichler WJ (1998b) Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific ab+ T cell clones. Int Immunol 10:507-515.